Literature DB >> 20399743

Regulation of GSK-3beta and beta-Catenin by Galphaq in HEK293T cells.

Sara Salmanian1, S Mahmoud A Najafi, Maryam Rafipour, Maryam Rezaei Arjomand, Hamideh Shahheydari, Sara Ansari, Leily Kashkooli, S Javad Rasouli, Marie Saghaeian Jazi, Tayebeh Minaei.   

Abstract

Recent studies have shown that heterotrimeric G proteins are involved in the regulation of the canonical Wnt/beta-Catenin pathway. However, the mechanism(s) behind this involvement is (are) poorly understood. Our previous results have shown that activation of Galphaq in Xenopus oocytes leads to inhibition of GSK-3beta and stabilization of the beta-Catenin protein, suggesting that Galphaq might stabilize beta-Catenin via inhibition of GSK-3beta. In this study, we have observed similar results in HEK293T cells. In these cells optimal activation of endogenous Galphaq by expressing M3-muscarinic acetylcholine receptor (with or without carbachol treatment), or exposing the cells to thrombin led to an increase of 2 to 3-fold in endogenous cytoplasmic beta-Catenin protein levels. In addition, expression of the activated mutant of Galphaq (GalphaqQL) dramatically enhanced accumulation of exogenous beta-Catenin with no effect on beta-catenin (CTNNB1) gene transcription. The Galphaq-mediated cellular accumulation of beta-Catenin was blocked by expression of a minigene encoding a Galphaq specific inhibitory peptide but not by a minigene encoding a Galphas blocking peptide. Also, expression of GalphaqQL led to a significant reduction in GSK-3beta kinase activity, supporting the idea that the positive role of Galphaq signaling in inducing cellular accumulation of beta-Catenin is mediated through inhibition of GSK-3beta. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399743     DOI: 10.1016/j.bbrc.2010.04.087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Denervation suppresses gastric tumorigenesis.

Authors:  Chun-Mei Zhao; Yoku Hayakawa; Yosuke Kodama; Sureshkumar Muthupalani; Christoph B Westphalen; Gøran T Andersen; Arnar Flatberg; Helene Johannessen; Richard A Friedman; Bernhard W Renz; Arne K Sandvik; Vidar Beisvag; Hiroyuki Tomita; Akira Hara; Michael Quante; Zhishan Li; Michael D Gershon; Kazuhiro Kaneko; James G Fox; Timothy C Wang; Duan Chen
Journal:  Sci Transl Med       Date:  2014-08-20       Impact factor: 17.956

2.  A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex.

Authors:  Melissa L Perreault; Jace Jones-Tabah; Brian F O'Dowd; Susan R George
Journal:  Int J Neuropsychopharmacol       Date:  2012-07-25       Impact factor: 5.176

3.  The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis.

Authors:  Costa Vakalopoulos
Journal:  Front Pharmacol       Date:  2014-12-15       Impact factor: 5.810

4.  Beta-catenin Forms Protein Aggregation at High Concentrations in HEK293TCells.

Authors:  Marie Saghaeian Jazi; Seyed Mahmoud Arab Najafi
Journal:  Iran J Med Sci       Date:  2017-01

Review 5.  The Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy.

Authors:  S Mahmoud A A Najafi
Journal:  Iran Biomed J       Date:  2020-04-29

6.  G-Alpha Subunit Abundance and Activity Differentially Regulate β-Catenin Signaling.

Authors:  Arshiya Banu; Karen J Liu; Alistair J Lax; Agamemnon E Grigoriadis
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

7.  Inhibitors of Gq signalling down-regulate β-catenin expression & function in human colon cancer cells.

Authors:  Nasim Forghani; S Mahmoud A Najafi
Journal:  Indian J Med Res       Date:  2021-06       Impact factor: 5.274

Review 8.  Vagotomy and Gastric Tumorigenesis.

Authors:  Hanne-Line Rabben; Chun-Mei Zhao; Yoku Hayakawa; Timothy C Wang; Duan Chen
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.